Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis (original) (raw)
References
Pendyala LK, Li J, Shinke T, Geva S, Yin X, Chen JP, et al. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc Interv. 2009;2:253–62. Article Google Scholar
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202. Article Google Scholar
Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701–5. Article Google Scholar
Seabra-Gomes R. Percutaneous coronary interventions with drug eluting stents for diabetic patients. Heart. 2006;92:410–9. Article Google Scholar
Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, et al. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J Am Coll Cardiol. 2008;51:2123–9. Article Google Scholar
Pendyala LK, Yin X, Li J, Chen JP, Chronos N, Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC Cardiovasc Interv. 2009;2:1169–77. Article Google Scholar
Le Y, Gong W, Li B, Dunlop NM, Shen W, Su SB, et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol. 1999;163:6777–84. Google Scholar
Forsman H, Bylund J, Oprea TI, Karlsson A, Boulay F, Rabiet MJ, et al. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop. Biochim Biophys Acta. 2013;1833:1914–23. Article Google Scholar
Kwon YW, Heo SC, Jang IH, Jeong GO, Yoon JW, Mun JH, et al. Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm. Wound Repair Regen. 2015;23(4):575–82. Article Google Scholar
Heo SC, Kwon YW, Jang IH, Jeong GO, Yoon JW, Kim CD, et al. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells. Stem Cells. 2014;32:779–90. Article Google Scholar
Miao Z, Premack BA, Wei Z, Wang Y, Gerard C, Showell H, et al. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23. J Immunol. 2007;178:7395–404. Article Google Scholar
Lee MS, Yoo SA, Cho CS, Suh PG, Kim WU, Ryu SH. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol. 2006;177:5585–94. Article Google Scholar
Meyers SR, Kenan DJ, Khoo X, Grinstaff MW. Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. Biomacromolecules. 2011;12:533–9. Article Google Scholar
Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol. 2005;45:1574–9. Article Google Scholar
Remuzzi A, Mantero S, Colombo M, Morigi M, Binda E, Camozzi D, et al. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng. 2004;10:699–710. Article Google Scholar
Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL. Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: role of CD44 and implications for constrictive remodeling. Circ Res. 2001;88:77–83. Article Google Scholar
Lim KS, Bae IH, Kim JH, Park DS, Kim JM, Sim DS, et al. Mechanical and histopathological comparison between commercialized and newly designed coronary bare metal stents in a porcine coronary restenosis model. Chonnam Med J. 2013;49:7–13. Article Google Scholar
Bae IH, Lim KS, Park JK, Park DS, Lee SY, Jang EJ, et al. Mechanical behavior and in vivo properties of newly designed bare metal stent for enhanced flexibility. J Indust Eng Chem. 2015;21:1295–300. Article Google Scholar
Buszman P, Trznadel S, Zurakowski A, Milewski K, Kinasz L, Krol M, et al. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions. Kardiol Pol. 2007;65:1041–6 discussion 47-8. Google Scholar
Seo JK, Choi SY, Kim Y, Baek SH, Kim KT, Chae CB, et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol. 1997;158:1895–901. Google Scholar
Ma X, Oyamada S, Gao F, Wu T, Robich MP, Wu H, et al. Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. J Pharm Biomed Anal. 2011;54:807–11. Article Google Scholar
Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, et al. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv. 2008;1:143–53. Article Google Scholar
Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol. 2003;162:899–908. Article Google Scholar
Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware M Jr, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001;103:2289–95. Article Google Scholar
Seidel CL. Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair. Arterioscler Thromb Vasc Biol. 1997;17:1868–71. Article Google Scholar
Meng S, Liu Z, Shen L, Guo Z, Chou LL, Zhong W, et al. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials. 2009;30:2276–83. Article Google Scholar
Hou C, Yuan Q, Huo D, Zheng S, Zhan D. Investigation on clotting and hemolysis characteristics of heparin-immobilized polyether sulfones biomembrane. J Biomed Mater Res A. 2008;85:847–52. Article Google Scholar
Wissink MJ, Beernink R, Pieper JS, Poot AA, Engbers GH, Beugeling T, et al. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials. 2001;22:151–63. Article Google Scholar
Kim JM, Bae IH, Lim KS, Park JK, Park DS, Lee SY, et al. A method for coating fucoidan onto bare metal stent and in vivo evaluation. Prog Org Coat. 2015;78:348–56. Article Google Scholar
Vetrovec GW, Rizik D, Williard C, Snead D, Piotrovski V, Kopia G. Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions. Catheter Cardiovasc Interv. 2006;67:32–7. Article Google Scholar
Park S, Bhang SH, La WG, Seo J, Kim BS, Char K. Dual roles of hyaluronic acids in multilayer films capturing nanocarriers for drug-eluting coatings. Biomaterials. 2012;33:5468–77. Article Google Scholar
Che HL, Bae IH, Lim KS, Song IT, Lee H, Muthiah M, et al. Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model. Biomaterials. 2012;33:8548–56. Article Google Scholar
Alfonso F, Dutary J, Paulo M, Perez-Vizcayno MJ. Paclitaxel-eluting balloons for sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:716 author reply 16-7. Article Google Scholar
Durand E, Scoazec A, Lafont A, Boddaert J, Al Hajzen A, Addad F, et al. In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation. 2004;109:2503–6. Article Google Scholar
Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–63. Article Google Scholar